Back
Fulcrum Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
40
FULC
Fulcrum Therapeutics
Last Price:
3.45
Seasonality Move:
85.55%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing buying pressure, which is a positive indicator for future bullish movement.
Fulcrum Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.26 | Buy |
| 20-day SMA: | 3.36 | Buy |
| 50-day SMA: | 4.57 | Sell |
| 200-day SMA: | 7.42 | Sell |
| 8-day EMA: | 3.31 | Buy |
| 20-day EMA: | 3.46 | Sell |
| 50-day EMA: | 4.48 | Sell |
| 200-day EMA: | 6.32 | Sell |
Fulcrum Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 43.09 | Sell |
| Chaikin Money Flow: | 1011197 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.23 - 3.63) | Buy |
| Bollinger Bands (100): | (3.84 - 8.74) | Sell |
Fulcrum Therapeutics Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fulcrum Therapeutics Stock
Is Fulcrum Therapeutics Stock a Buy?
- Fulcrum Therapeutics share price is 3.44 while FULC 8-day simple moving average is 3.26, which is a Buy signal.
- The stock price of FULC is 3.44 while Fulcrum Therapeutics 20-day SMA is 3.36, which makes it a Buy.
- Fulcrum Therapeutics 50-day simple moving average is 4.57 while FULC share price is 3.44, making it a Sell technically.
- FULC stock price is 3.44 and Fulcrum Therapeutics 200-day simple moving average is 7.42, creating a Sell signal.
FULC Technical Analysis vs Fundamental Analysis
Sell
40
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy or a Sell?
-
Fulcrum Therapeutics stock is rated a Sell
The current Fulcrum Therapeutics [FULC] share price is $3.44. The Score for FULC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Fulcrum Therapeutics Stock Info
Market Cap:
214.66M
Price in USD:
3.44
Share Volume:
1.45M
Fulcrum Therapeutics 52-Week Range
52-Week High:
13.70
52-Week Low:
2.87
Sell
40
Fulcrum Therapeutics (FULC)
is a Sell
Fulcrum Therapeutics Share Price Forecast
-
What is the Fulcrum Therapeutics stock price today?
The Fulcrum Therapeutics stock price is 3.44 USD today. -
Will FULC stock go up or go down?
Fulcrum Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Fulcrum Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fulcrum Therapeutics is overvalued.
Is Fulcrum Therapeutics Stock a Buy?
- Fulcrum Therapeutics share price is 3.44 while FULC 8-day exponential moving average is 3.31, which is a Buy signal.
- The stock price of FULC is 3.44 while Fulcrum Therapeutics 20-day EMA is 3.46, which makes it a Sell.
- Fulcrum Therapeutics 50-day exponential moving average is 4.48 while FULC share price is 3.44, making it a Sell technically.
- FULC stock price is 3.44 and Fulcrum Therapeutics 200-day simple moving average is 6.32, creating a Sell signal.
Fundamental Analysis of Fulcrum Therapeutics
Is Fulcrum Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and a decrease next year of $0.78 per share.
Technical Analysis of Fulcrum Therapeutics
Should I short Fulcrum Therapeutics stock?
- FULC Moving Average Covergence Divergence (MACD) indicator is -0.31, suggesting Fulcrum Therapeutics is a Sell
- Fulcrum Therapeutics Relative Strength Index (RSI) is 43.09, which suggest Fulcrum Therapeutics is oversold
- The Bollinger Bands (25) for Fulcrum Therapeutics is (3.23 - 3.63), which suggest Fulcrum Therapeutics is a Sell
- The Bollinger Bands (100) for Fulcrum Therapeutics is (3.84 - 8.74), which suggest Fulcrum Therapeutics is a Sell
* Fulcrum Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.